Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)

home / insights / treatment-and-management-of-lung-large-cell-neuroendocrine-carcinoma-lcnec

Panelists discuss how the management of lung large cell neuroendocrine carcinoma (LCNEC) involves a multidisciplinary approach, focusing on molecular characterization, biomarker testing, and emerging treatment options, including novel targeted therapies and ongoing clinical trials.

Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

Martin Dietrich, MD, PhD;Soo-Ryum Yang, MD
November 25th 2024

Panelists discuss how lung large cell neuroendocrine carcinoma (LCNEC) is characterized by its biology, incidence, risk factors, clinical presentation, and prognosis, while addressing the challenges, unmet needs, and the trial data required to guide testing and treatment guidelines for this rare cancer.

An Overview of the Molecular Characterization of Lung LCNEC

EP. 2: An Overview of the Molecular Characterization of Lung LCNEC

Martin Dietrich, MD, PhD;Soo-Ryum Yang, MD
November 25th 2024

Panelists discuss how the characterization and classification of lung large cell neuroendocrine carcinoma (LCNEC) has evolved over the past decade, highlighting the clinical heterogeneity of these tumors and how it is navigated in clinical practice.